T-cell deficiency in patients with squamous cell cancer of the head and neck.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 1101724)

Published in Am J Surg on October 01, 1975

Authors

H J Wanebo, M Y Jun, E W Strong, H Oettgen

Articles citing this

Squamous cell carcinoma of the tongue among young Indian adults. Neoplasia (2001) 1.04

Aetiology of oral cancer in patients less than or equal to 30 years of age. Br J Cancer (1989) 0.92

Dental therapy before and after radiotherapy--an evaluation on patients with head and neck malignancies. Clin Oral Investig (2008) 0.89

Need for immunologic stimulators during immunosuppression produced by major cancer surgery. Ann Surg (1985) 0.87

Nutritional status and general immune competence in patients with head and neck cancer. J R Soc Med (1981) 0.86

[Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)]. Arch Otorhinolaryngol (1981) 0.81

Observations on immunologic parameters in laryngeal cancer patients. Arch Otorhinolaryngol (1983) 0.80

Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas. Br J Cancer (1999) 0.80

Total T lymphocytes in primary bronchial carcinoma. Thorax (1977) 0.79

T- and B-lymphocyte subpopulations in pre-invasive and invasive carcinoma of the cervix. Clin Exp Immunol (1977) 0.78

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients. Ann Surg (1982) 0.78

Immunologic parameters in patients with thyroid cancer. Arch Otorhinolaryngol (1986) 0.75

Depression of cellular immunity as an index of malnutrition in surgical patients. Br Med J (Clin Res Ed) (1981) 0.75

Efficacy of Varunadi Ghritha (polyherbal compound) in treated head and neck cancer cases as a biological response modifier. Ayu (2014) 0.75

Overview of immunology of oral squamous cell carcinoma. J Pharm Bioallied Sci (2016) 0.75

Variable course of progression of oral cavity and oropharyngeal carcinoma in young adults. Contemp Oncol (Pozn) (2013) 0.75

Immunobiology of operable breast cancer: an assessment of biologic risk by immunoparameters. Ann Surg (1976) 0.75

[Immunocytochemical venous blood studies in patients with manifest oral cavity carcinomas, oral precancerous conditions, benign tumors and in chronic alcoholic patients]. Mund Kiefer Gesichtschir (1997) 0.75

Articles by these authors

(truncated to the top 100)

Benign solitary Schwannomas (neurilemomas). Cancer (1969) 4.74

The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47

Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26

Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89

Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

Adenoid cystic carcinoma of salivary origin. A clinicopathologic study of 242 cases. Am J Surg (1974) 2.30

Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest (1999) 2.09

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04

Sweat gland carcinoma: a clinico-pathologic study of 83 patients. Ann Surg (1971) 1.94

The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88

Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78

Anorectal melanoma. Cancer (1981) 1.77

Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1. Cell (1986) 1.77

Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77

Detailed quality of life assessment in patients treated with primary radiotherapy for squamous cell cancer of the base of the tongue. Head Neck (1997) 1.71

Mucoepidermoid carcinoma of salivary gland origin. A clinicopathologic study of 367 cases. Am J Surg (1978) 1.67

Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65

Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg (1986) 1.59

The delta- and epsilon-chains of the human T3/T-cell receptor complex are distinct polypeptides. Nature (1985) 1.58

Proceedings: Ameloblastoma of maxilla and mandible. Cancer (1974) 1.56

Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52

Tumors of minor salivary origin. A clinicopathologic study of 492 cases. Cancer (1973) 1.50

Estrogen and progesterone receptor content in human thyroid disease. Am J Clin Pathol (1993) 1.49

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49

Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg (1992) 1.48

Cervical nodal metastases of unknown origin. Am J Surg (1970) 1.46

Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer (1995) 1.45

Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44

Malignant mixed tumor of salivary origin: a clinicopathologic study of 146 cases. Cancer (1977) 1.39

Significance of positive margins in oral cavity squamous carcinoma. Am J Surg (1990) 1.37

Position-dependent inhibition of class-switch recombination by PGK-neor cassettes inserted into the immunoglobulin heavy chain constant region locus. Proc Natl Acad Sci U S A (1999) 1.36

Tumors of the major salivary glands in children. Cancer (1972) 1.33

Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg (1989) 1.32

Granular cell myoblastoma. Cancer (1970) 1.31

E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children. Cancer (1970) 1.31

Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30

Soft tissue sarcomas of the head and neck in adults. Am J Surg (1990) 1.28

Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28

A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27

Critical assessment of supraomohyoid neck dissection. Am J Surg (1988) 1.27

The importance of clinical staging of minor salivary gland carcinoma. Am J Surg (1991) 1.26

Cancer of the parotid gland. A clinicopathologic study of 288 primary cases. Am J Surg (1975) 1.25

Craniofacial resections for tumors involving the base of the skull. Am J Surg (1987) 1.24

Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24

Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy. Arch Otolaryngol Head Neck Surg (1990) 1.24

Adenoid cystic carcinoma: factors influencing survival. Am J Surg (1979) 1.23

Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22

Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22

Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131) Ann Surg (1994) 1.21

Prognostic factors for recurrence and survival in head and neck soft tissue sarcomas. Cancer (1994) 1.21

Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20

Complications of craniofacial resection for tumors involving the anterior skull base. Head Neck (1994) 1.20

Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19

The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer (1992) 1.18

Squamous carcinoma of the gums. Am J Surg (1988) 1.16

Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16

Craniofacial resection for malignant tumors involving the anterior skull base. Arch Otolaryngol Head Neck Surg (1997) 1.15

The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg (1979) 1.13

Failure at the primary site following multimodality treatment in advanced head and neck cancer. Head Neck Surg (1984) 1.12

Resolution of bronchial hyperresponsiveness and pulmonary inflammation is associated with IL-3 and tissue leukocyte apoptosis. J Immunol (2001) 1.12

Quality of life of maxillectomy patients using an obturator prosthesis. Head Neck (1996) 1.12

The management of chyle fistula. Laryngoscope (1990) 1.12

Acinic cell carcinoma of salivary origin. A clinicopathologic study of 67 cases. Cancer (1978) 1.11

Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10

Cricopharyngeal obstruction in inflammatory myopathy (polymyositis/dermatomyositis). Report of three cases and review of the literature. Arthritis Rheum (1985) 1.10

Patterns of failure in carcinoma of the nasopharynx: I. Failure at the primary site. Int J Radiat Oncol Biol Phys (1985) 1.10

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08

Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer. Head Neck (1997) 1.08

Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07

Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 1.06

Preoperative x-ray therapy as an adjunct to radical neck dissection. Cancer (1966) 1.06

CIS-Dichlorodiammineplatinum(II) in the treatment of epidermoid carcinoma of the head and neck. Cancer Treat Rep (1977) 1.06

Plasmacytoma of paranasal sinuses and nasal cavity. Arch Otolaryngol (1973) 1.06

Preoperative radiation and radical neck dissection. Surg Clin North Am (1969) 1.06

Adenocarcinoma of salivary origin. Clinicopathologic study of 204 patients. Am J Surg (1982) 1.06

Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05

Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 1.04

Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: a matched-pair analysis. Am J Surg (1993) 1.04

Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood (2001) 1.03

The T3/T cell receptor complex: antigenic distinction between the two 20-kd T3 (T3-delta and T3-epsilon) subunits. EMBO J (1985) 1.03

Mandibular "swing" approach for oral and oropharyngeal tumors. Head Neck Surg (1981) 1.03

Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg (1974) 1.02

In vivo localization of cloned IL-2-dependent T cells. Cell Immunol (1983) 1.02

Osteogenic sarcoma of the facial and cranial bones. A review of forty-three cases. Am J Surg (1971) 1.02

Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02

Mucosal melanomas of the head and neck. Am J Surg (1977) 1.01

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy. Cancer (1978) 1.00

Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00

Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience. Med Pediatr Oncol (1998) 1.00

Pleural mesothelioma. Cancer (1976) 0.99

Postoperative radiation therapy for major salivary gland malignancies. J Surg Oncol (1990) 0.99

Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck. Am J Surg (1976) 0.98

Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer (1970) 0.98

Maxillectomy and its classification. Head Neck (1997) 0.97

Clinicopathologic study of cutaneous melanoma of the head and neck. Am J Surg (1972) 0.97

Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97